Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.

https://read.qxmd.com/read/39626297/elotuzumab-in-combination-with-pomalidomide-bortezomib-and-dexamethasone-in-relapsed-and-refractory-multiple-myeloma?uac=148436CN&ecd=wnl_readmost_241213&sso=true&redirected=slug